Exelixis (EXEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2024, Exelixis (EXEL) reported revenue of $566.76 million, up 18.2% over the same period last year. EPS came in at $0.55, compared to $0.33 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $563.12 million, representing a surprise of +0.65%. The company delivered an EPS surprise of +7.84%, with the consensus EPS estimate being $0.51.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Exelixis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Net product: $515.23 million versus $505.98 million estimated by 11 analysts on average. Compared to the year-ago quarter, this number represents a +20% change. Revenues- License: $49.34 million compared to the $54.80 million average estimate based on seven analysts. The reported number represents a change of +9.1% year over year. Revenues- Collaboration services: $2.18 million compared to the $1.94 million average estimate based on three analysts. The reported number represents a change of -57.2% year over year. View all Key Company Metrics for Exelixis here>>>Shares of Exelixis have returned -5.1% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelixis, Inc. (EXEL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks